Sign in or Register
Home
The story of Aurigene
The Aurigene approach
Our impact
Media center
Our publications
About Us
Our journey
Our purpose
Our Core Values
Our milestones
Management Team
Board of Directors
Scientific Advisors
Science
Science
Our research
Our platform technologies
Our publications
Pipeline
Proprietary Pipeline
Partnered Programs in Clinic
News and Events
Aurigene in the media
News
Events
Careers
Life at Aurigene
Working at Aurigene
Perks at Aurigene
Teamwork
Current Openings
A word from Aurigeneans
Contact Us
Home
The story of Aurigene
The Aurigene approach
Our impact
Media center
Our publications
About Us
Our journey
Our purpose
Our Core Values
Our milestones
Management Team
Board of Directors
Scientific Advisors
Science
Science
Our research
Our platform technologies
Our publications
Pipeline
Proprietary Pipeline
Partnered Programs in Clinic
News and Events
Aurigene in the media
News
Events
Careers
Life at Aurigene
Working at Aurigene
Perks at Aurigene
Teamwork
Current Openings
A word from Aurigeneans
Contact Us
Targeting cancer with selective CBP/p300 bromodomain inhibitors
Home
Targeting cancer with selective CBP/p300 bromodomain inhibitors
<< Back
April 27, 2023
by admin aurigene
Targeting cancer with selective CBP/p300 bromodomain inhibitors
Previous Post
Next Post
Apply Now
×
Your Full name
Your email
Your Mobile
Your Address(optional)
Attach your CV Here
(Attach .doc, .docx, .pdf files only (Min of 3MB)
)
Tell us amazing about you
